Comorbid Curiosity: Which One Doesn't Pertain?

Poll

Conditions associated with long-term diabetes affect myriad organs and systems. Which one of these comorbidities is not associated with the disease?

There are several well-known comorbidities associated with long-term diabetes, which include cardiovascular disease, hyperlipidemia, and obesity.

In addition to these, all of the following are common prevalent conditions in persons with diabetes except...

A. Reduced testosterone levels
B. Fractures
C. Migraine headaches
D. Cognitive impairment
Related Videos
Erin Michos, MD | Credit: Johns Hopkins University
Natalie McCormick, PhD | Credit: American College of Rheumatology
Medha Munshi, MD, (Courtesy: Harvard Health)
David Maahs, MD, PhD
Related Content

Applying New NAFLD Recommendations in Type 2 Diabetes, with Sarah Wheeler, PharmD, and John Bucheit, PharmD

September 22nd 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Diabetes Dialogue: Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical

September 19th 2023

Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO

June 29th 2023

Evening Chronotypes Linked to Unhealthy Lifestyle, Increased Diabetes Risk in Women

September 12th 2023

Study Examines Prevalence, Drivers of Racial Disparities in T2D Following Gestational Diabetes

September 11th 2023

Applying New NAFLD Recommendations in Type 2 Diabetes, with Sarah Wheeler, PharmD, and John Bucheit, PharmD

September 22nd 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Diabetes Dialogue: Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical

September 19th 2023

Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO

June 29th 2023

Evening Chronotypes Linked to Unhealthy Lifestyle, Increased Diabetes Risk in Women

September 12th 2023

Study Examines Prevalence, Drivers of Racial Disparities in T2D Following Gestational Diabetes

September 11th 2023

Applying New NAFLD Recommendations in Type 2 Diabetes, with Sarah Wheeler, PharmD, and John Bucheit, PharmD

September 22nd 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Diabetes Dialogue: Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical

September 19th 2023

Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO

June 29th 2023

Evening Chronotypes Linked to Unhealthy Lifestyle, Increased Diabetes Risk in Women

September 12th 2023

Study Examines Prevalence, Drivers of Racial Disparities in T2D Following Gestational Diabetes

September 11th 2023
© 2023 MJH Life Sciences

All rights reserved.